In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

MannKind closed 2025 on a high note, marked by milestones that reinforce our growth trajectory—including the acquisition of scPharmaceuticals and a record-setting fourth quarter surpassing $100 ...

Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year ...

Get the latest Brooks Laboratories share price today on NSE & BSE. Explore Brooks Laboratories stock analysis, financial performance, market capitalization, dividend history, and future outlook for ...

Blowing oxygen into molten steel in vacuum conditions saves time and money when compared to conventional steelmaking methods.

"Angle Advisors played a critical role in the successful sale of Forecast 3D, bringing both industry insight and rigorous transaction execution. Their team managed a complex process with ...

This year, eight items have been selected as targets for focused selective review under automobile insurance, including ...

Onyx Biotec Ltd. is a pharmaceutical company engaged in the manufacture, sale, and distribution of generic and proprietary pharmaceutical products. It develops, manufactures and distributes generic ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

Bareilly: The son of jailed Ittehad-e-Millat Council (IMC) chief Maulana Tauqeer Raza Khan was detained by police in ...

Estimated YUTREPIA net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in Jun ...